ArticleSensors (Basel, Switzerland)2026
HGSM-YOLO: A Small-Lesion-Oriented Lightweight YOLO11n Framework for Citrus Leaf Disease Detection.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate and rapid detection of citrus leaf diseases is important for early diagnosis, precision orchard management, and the reduction of economic losses in citrus production. Automatic detection remains difficult because early lesions are often small and irregular. Several disease categories also share similar visual appearances, and localization is easily affected by veins, shadows, and cluttered backgrounds. To address these task-specific challenges, we propose HGSM-YOLO, where HGSM denotes the coordinated use of heterogeneous convolution, a GSConv-based slim neck, and multi-scale dilated local attention. The framework is built on YOLO11n because its 2.59 M-parameter and 6.4 GFLOP design provides a stringent compact baseline for edge-oriented improvement. The method follows a hierarchical design: C3k2-HetConv preserves lesion edges and local morphology in the backbone; the GSConv-based slim neck reduces part of the feature fusion cost; and an MSDA module in the high-resolution P3 branch enhances the context of small lesions. Following model selection on the validation split, the final locked models were evaluated once on the held-out test split, with HGSM-YOLO reaching 77.5% precision, 66.8% recall, 71.7% F1-score, 70.8% mAP@0.5, and 44.2% mAP@0.5:0.95, compared with 68.5%, 61.5%, 64.8%, 66.0%, and 40.2% for YOLO11n. A stratified outer five-fold cross-validation further yields 71.0% ± 1.4% mAP@0.5 and 44.4% ± 1.1% mAP@0.5:0.95 for HGSM-YOLO, versus 65.9% ± 1.1% and 40.2% ± 0.9% for YOLO11n. On the independent 1871-image citrus-leaf-disease-2 dataset, retraining under the same protocol gives 94.4% mAP@0.5 for HGSM-YOLO versus 92.2% for YOLO11n and 93.1% for the public Roboflow YOLOv11 reference model. The complete HGSM-YOLO architecture uses 7.2 GFLOPs, 2.82 M parameters, and runs at 90.9 FPS on the RTX 4090, compared with 6.4 GFLOPs, 2.59 M parameters, and 110.1 FPS for the baseline. Thus, the contribution provides a recall- and localization-oriented accuracy-efficiency trade-off rather than universal superiority in every individual metric.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.